Intellia Therapeutics, Inc.

40 Erie Street Suite 130, Cambridge, MA 02139

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases

Click to rate this company
[Total: 0 Average: 0]

3.1

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

Energy Efficient Buildings: Reduction efforts with the installation of beverage machines that reduce or eliminate aluminum can or pod usage. Composting services and removal of plasticware. Single-stream recycling at our 2nd largest building. Dual-stream recycling at all other buildings. Non-automobile transportation benefits. Access to electric vehicle charging stationsOur employees frequently participate in a variety of community volunteering and donation programs. 10+ charitable organizations in 2022, with over 100 employees volunteering in various service projects. $40K+ corporate and employee donations to UNCF. 350 science experiment kits were assembled to support girls looking to work in STEM careers. 2 blood donation drives through Massachusetts General HospitalGood corporate governance is important to ensure Intellia is managed for the long-term benefit of our stockholders. Our Code of Business Conduct and Ethics applies to all officers and employees. We have established committee charters for the Audit Committee, Nominating and Corporate Governance Committee, and Compensation and Talent Development Committee.Intellia Therapeutics’ financial sustainability is integrally linked to its commitment to innovation. The company’s investment in research and development drives advancements in biopharmaceutical solutions, leading to improved patient care and scientific progress. By embracing strategic financial management and nurturing innovation, Intellia Therapeutics sustains long-term value creation while advancing the trajectory of biopharmaceutical research and development.At Intellia, we recognize the importance of medical research as part of the process for developing innovative medicines for patients. We are committed to conducting clinical trials in accordance with the highest ethical, scientific and safety standards to ensure we are protecting the rights and wellbeing of the individuals enrolled in our clinical trials. All Intellia-sponsored clinical studies are designed and conducted to integrate ethical and safety procedures and protocols that meet or exceed all applicable local laws and regulations as well as global guidelines. Intellia has implemented and is maintaining quality assurance and quality control systems with written standard operating procedures to help ensure that trials are conducted and data are generated, documented and reported in compliance with the protocol, Good Clinical Practice standards defined by the International Conference on Harmonization (ICH) guidance, and the applicable regulatory requirements.

Eligible Awards

Coming Soon






Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$52,120,000.00

Website Traffic

Employee Rating

4.1

Customer Rating

2.5

Company Size

100-1000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.